The new post-hoc analysis of MRI findings demonstrated that subclinical spinal cord lesions were associated with future NMOSD attacks, as well. UPLIZNA is the first and only targeted CD19+ B-cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback